Lucid Diagnostics Inc. (NASDAQ: LUCD) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT LUCID DIAGNOSTICS INC.

Lucid Diagnostics Inc. (NASDAQ: LUCD)
Listen to this Section


$0.99
-0.0270 ( -2.65% ) 390.9K

Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.

Market Data


Open $0.99
Previous Close $1.02
Volume 390.9K
Market Cap $191.71M
Day Range $0.98 - $1.03
52 Week Range $0.90 - $1.63
Shares Outstanding 190.76M
Change % -2.65%
Net Change ▼ -0.0270
Insider Ownership -0.18%
Exchange NASDAQ
SectorHealthcare
IndustryBiotechnology: Electromedical & Electrotherapeutic Apparatus
IPO Year2021
CountryUnited States
UnderwriterCantor Fitzgerald, Canaccord Genuity, BTIG, Needham & Co., more

Insider Ownership Transactions

Total Amount Purchased: -8,971,525.00

Date Type Amount Purchased Purchaser
2024-02-23 Sale -150000.00 Cox James L
2024-02-23 Sale -150000.00 SOKOLOV JACQUE J
2024-02-20 Sale -3331747.00 PAVmed Inc.
2024-01-30 Sale -3331771.00 PAVmed Inc.
2023-09-27 Sale -200.00 Lapidus Stanley
2023-09-22 Sale -3405.00 Lapidus Stanley

SEC Filings


Form Type Description Pages Date
8-k 8K-related 13 Nov 12, 2025
10-q Quarterly Reports 72 Nov 12, 2025
3 Insider transactions 1 Oct 07, 2025
4 Insider transactions 1 Oct 07, 2025
8-k 8K-related 14 Sep 25, 2025
8-k 8K-related 14 Sep 11, 2025
8-k 8K-related 20 Sep 10, 2025
4 Insider transactions 1 Aug 22, 2025
8-k 8K-related 13 Aug 13, 2025
10-q Quarterly Reports 72 Aug 12, 2025

Latest News


× Before browsing our site, please accept our cookies policy